Connect
← Return to Boehringer Ingelheim AIRTIVITY clinical trial
Discussion
Boehringer Ingelheim AIRTIVITY clinical trial
MAC & Bronchiectasis | Last Active: 1 day ago | Replies (52)Comment receiving replies
I also recieved a call from Boehringer and pre-registered. My home hospital University of Vermont is not listed as a trial site, but is listed as a “Center of Excellence” for BE. I go south (Florida) in the Winter months and get treatment at Mayo Jax, which is a trial site. I asked the question if I could participate and have a cooperative and coordinated effort from both hospitals depending on where I am at that time for monitoring/follow-up. The lady that registered me didn’t know the answer, but registered me anyway as I told her I possibly could fly to Jacksonville every 2-3 months for the required follow up appointment. I also let my Pulmonologist at Mayo Clinic know and he messaged me back and stated that he forwarded my name to the clinical trials team. 🤞🤞🤞. Does anyone know if this medication Artivity is the same or similar to Brensocatib?
Replies to "I also recieved a call from Boehringer and pre-registered. My home hospital University of Vermont is..."
My understanding is that Airtivity is a DPP1 inhibitor similar to brensocatib but with different mechanism of action. It's a ways out for trial completion, 2028. Sigh.
Connect
With the preregistration they actually don’t give you more information than that the trial is up to 18 months, every month a meeting/ phone call from the site and every 3 months a check up at the site and that you will receive another phone call when they are ready to contact you.